ArticleMediators of inflammation2026
Allicin Attenuates Sepsis-Induced Acute Kidney Injury by Inhibiting Pyroptosis Through Negative Regulation of the PI3K/AKT Pathway.
Article in Mediators of inflammation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Allicin Attenuates Sepsis-Induced Acute Kidney Injury by Inhibiting Pyroptosis Through Negative Regulation of the PI3K/AKT Pathway.Mediators of inflammation · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Pyroptosis is a critical mechanism leading to sepsis-induced acute kidney injury (S-AKI). Allicin, an organosulfur compound extracted from garlic bulbs, protects against S-AKI through its anti-pyroptotic role, but the underlying pathophysiological mechanisms remain largely unknown. In in vivo and in vitro experiments, rats and HK-2 cells were induced by caecal ligation and puncture (CLP) and lipopolysaccharides (LPSs), respectively. They were then treated with allicin, insulin-like growth factor-1 (IGF-1, a PI3K/AKT agonist), or both. In this study, we found that the levels of p-PI3K, p-AKT, NF-κB, NLRP3, caspase-1, gasdermin D (GSDMD)-N, IL-1β, IL-18 and lactate dehydrogenase (LDH) were significantly increased, which was accompanied by kidney tissue and HK-2 cell pyroptosis, eventually leading to elevated serum creatinine (Scr) and blood urea nitrogen (BUN) levels, increased 7-day mortality and reduced HK-2 cell activity in CLP-induced rats and LPS-induced HK-2 cells, respectively. Moreover, we observed that allicin significantly reduced the levels of p-PI3K, p-AKT, NF-κB, NLRP3, caspase-1, GSDMD-N, IL-1β, IL-18 and LDH and inhibited pyroptosis in renal tissues and HK-2 cells, ultimately resulting in improved kidney function, 7-day survival, and enhanced HK-2 cell activity in CLP-induced rats and LPS-induced HK-2 cells. Furthermore, our results demonstrate that agonism of the PI3K/AKT pathway-by using IGF-1-could reverse the abovementioned protective role of allicin, accompanied by increased phosphorylation of PI3K and AKT in vivo and in vitro. Overall, the findings of this study demonstrate that the protective effect of allicin on S-AKI is largely dependent on the inhibition of pyroptosis through the negative regulation of the PI3K/AKT pathway.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.